Lucid Diagnostics Inc reports results for the quarter ended in June - Earnings Summary

Lucid Diagnostics

15/08/2023 14:31

* Lucid Diagnostics Inc  LUCD.OQ  reported a quarterly
adjusted
loss of 23 cents​​ per share for the quarter ended in June. The
mean expectation of five analysts for the quarter was for a loss
of 32 cents per share.
    * Revenue was $159.00 thousand​; analysts expected $620.00
thousand. 
    * Lucid Diagnostics Inc's reported EPS for the quarter was a
loss
of 27 cents​.
    * The mean earnings estimate of analysts had risen by
about 3.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Lucid Diagnostics Inc shares had risen by 6.8% this
quarter and
gained 9.2% so far this year.
    * The company reported a quarterly loss of $11.38 million.
    * Wall Street's median 12-month price target for Lucid
Diagnostics
Inc is $3.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 15 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.32          -0.23          Beat
 Mar. 31 2023      -0.35          -0.40          Missed
 Dec. 31 2022      -0.38          -0.23          Beat
 Sep. 30 2022      -0.40          -0.39          Beat